Akumin Past Earnings Performance
Past criteria checks 0/6
Akumin's earnings have been declining at an average annual rate of -72.8%, while the Healthcare industry saw earnings declining at 6.7% annually. Revenues have been growing at an average rate of 35.2% per year.
Key information
-72.8%
Earnings growth rate
-70.3%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 35.2% |
| Return on equity | n/a |
| Net Margin | -34.7% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Is Akumin (TSE:AKU) Using Too Much Debt?
Apr 06
Akumin (TSE:AKU) Has A Somewhat Strained Balance Sheet
Jan 06Akumin Inc.'s (TSE:AKU) Intrinsic Value Is Potentially 83% Above Its Share Price
Oct 05Is Akumin (TSE:AKU) Using Too Much Debt?
Sep 02Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky
May 08A Look At The Fair Value Of Akumin Inc. (TSE:AKU)
Feb 05Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky
May 14Will The ROCE Trend At Akumin (TSE:AKU) Continue?
Mar 02Is Akumin (TSE:AKU) Using Too Much Debt?
Feb 04
Could The Akumin Inc. (TSE:AKU) Ownership Structure Tell Us Something Useful?
Jan 13Have Insiders Been Selling Akumin Inc. (TSE:AKU) Shares This Year?
Dec 23Will Akumin's (TSE:AKU) Growth In ROCE Persist?
Dec 02Should You Be Concerned About Akumin Inc.'s (TSE:AKU) ROE?
Jul 28Would Shareholders Who Purchased Akumin's(TSE:AKU) Stock Year Be Happy With The Share price Today?
Jul 10Does Akumin's (TSE:AKU) Statutory Profit Adequately Reflect Its Underlying Profit?
Jun 22Revenue & Expenses BreakdownBeta
How Akumin makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 738 | -256 | 52 | 0 |
| 30 Jun 23 | 744 | -227 | 51 | 0 |
| 31 Mar 23 | 751 | -161 | 51 | 0 |
| 31 Dec 22 | 750 | -157 | 52 | 0 |
| 30 Sep 22 | 744 | -147 | 33 | 0 |
| 30 Jun 22 | 666 | -94 | 36 | 0 |
| 31 Mar 22 | 543 | -71 | 30 | 0 |
| 31 Dec 21 | 421 | -43 | 35 | 0 |
| 30 Sep 21 | 309 | -30 | 8 | 0 |
| 30 Jun 21 | 264 | -36 | 14 | 0 |
| 31 Mar 21 | 242 | -37 | 27 | 0 |
| 31 Dec 20 | 246 | -37 | 27 | 0 |
| 30 Sep 20 | 256 | -15 | 28 | 0 |
| 30 Jun 20 | 261 | -5 | 28 | 0 |
| 31 Mar 20 | 267 | 4 | 31 | 0 |
| 31 Dec 19 | 247 | 9 | 25 | 0 |
| 30 Sep 19 | 216 | 8 | 34 | 0 |
| 30 Jun 19 | 186 | 6 | 42 | 0 |
| 31 Mar 19 | 169 | 7 | 45 | 0 |
| 31 Dec 18 | 155 | 5 | 57 | 0 |
| 30 Sep 18 | 144 | 5 | 52 | 0 |
| 30 Jun 18 | 129 | -5 | 50 | 0 |
| 31 Mar 18 | 109 | -6 | 43 | 0 |
| 31 Dec 17 | 90 | -8 | 36 | 0 |
| 30 Jun 17 | 62 | -4 | 28 | 0 |
| 30 Sep 16 | 46 | -2 | 20 | 0 |
| 30 Sep 15 | 35 | -3 | 17 | 0 |
Quality Earnings: AKU is currently unprofitable.
Growing Profit Margin: AKU is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AKU is unprofitable, and losses have increased over the past 5 years at a rate of 72.8% per year.
Accelerating Growth: Unable to compare AKU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AKU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.9%).
Return on Equity
High ROE: AKU's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.